The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Cancer Therapeutics and Supportive Care Drugs-Global Market Insights and Sales Trends 2025
Synopsis
The cancer supportive care product market consists of drugs intended to prevent or treat the symptoms of cancer, and reduce the side effects of cancer treatments. Instead of extending a patient’s life expectancy, the emphasis is on improving overall quality of life. The key indications covered in this report are cancer pain, oral mucositis, chemotherapy-induced neutropenia (CIN), chemotherapy-induced anemia (CIA), chemotherapy-induced nausea and vomiting (CINV) and bone metastasis. These indications are not only distressing for patients, but can also lead to treatment cessation, which in turn increases patient mortality. As the number of people being diagnosed with cancer grows and access to effective treatment that allows patients to survive longer increases, demand for safe and effective cancer supportive care drugs will rise.
The global Cancer Therapeutics and Supportive Care Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Cancer Therapeutics and Supportive Care Drugs in various end use industries. The expanding demands from the Hospital and Retail Pharmacies, are propelling Cancer Therapeutics and Supportive Care Drugs market. Cancer Therapeutics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Supportive Care Drugs segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cancer Therapeutics and Supportive Care Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cancer Therapeutics and Supportive Care Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cancer Therapeutics and Supportive Care Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cancer Therapeutics and Supportive Care Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cancer Therapeutics and Supportive Care Drugs covered in this report include Abbott Laboratories, AstraZeneca plc, Astellas Pharma, Bristol-Myers Squibb, Johnson & Johnson, Eli Lilly, Novartis, Pfizer and Sanofi, etc.
The global Cancer Therapeutics and Supportive Care Drugs market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
AstraZeneca plc
Astellas Pharma
Bristol-Myers Squibb
Johnson & Johnson
Eli Lilly
Novartis
Pfizer
Sanofi
Teva Pharmaceuticals
Takeda Pharmaceuticals
AbbVie
Global Cancer Therapeutics and Supportive Care Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cancer Therapeutics and Supportive Care Drugs market, Segment by Type:
Cancer Therapeutics
Supportive Care Drugs
Global Cancer Therapeutics and Supportive Care Drugs market, by Application
Hospital
Retail Pharmacies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Cancer Therapeutics and Supportive Care Drugs companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The cancer supportive care product market consists of drugs intended to prevent or treat the symptoms of cancer, and reduce the side effects of cancer treatments. Instead of extending a patient’s life expectancy, the emphasis is on improving overall quality of life. The key indications covered in this report are cancer pain, oral mucositis, chemotherapy-induced neutropenia (CIN), chemotherapy-induced anemia (CIA), chemotherapy-induced nausea and vomiting (CINV) and bone metastasis. These indications are not only distressing for patients, but can also lead to treatment cessation, which in turn increases patient mortality. As the number of people being diagnosed with cancer grows and access to effective treatment that allows patients to survive longer increases, demand for safe and effective cancer supportive care drugs will rise.
The global Cancer Therapeutics and Supportive Care Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Cancer Therapeutics and Supportive Care Drugs in various end use industries. The expanding demands from the Hospital and Retail Pharmacies, are propelling Cancer Therapeutics and Supportive Care Drugs market. Cancer Therapeutics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Supportive Care Drugs segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cancer Therapeutics and Supportive Care Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cancer Therapeutics and Supportive Care Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cancer Therapeutics and Supportive Care Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cancer Therapeutics and Supportive Care Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cancer Therapeutics and Supportive Care Drugs covered in this report include Abbott Laboratories, AstraZeneca plc, Astellas Pharma, Bristol-Myers Squibb, Johnson & Johnson, Eli Lilly, Novartis, Pfizer and Sanofi, etc.
The global Cancer Therapeutics and Supportive Care Drugs market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
AstraZeneca plc
Astellas Pharma
Bristol-Myers Squibb
Johnson & Johnson
Eli Lilly
Novartis
Pfizer
Sanofi
Teva Pharmaceuticals
Takeda Pharmaceuticals
AbbVie
Global Cancer Therapeutics and Supportive Care Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cancer Therapeutics and Supportive Care Drugs market, Segment by Type:
Cancer Therapeutics
Supportive Care Drugs
Global Cancer Therapeutics and Supportive Care Drugs market, by Application
Hospital
Retail Pharmacies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Cancer Therapeutics and Supportive Care Drugs companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Cancer Therapeutics and Supportive Care Drugs
1.1 Cancer Therapeutics and Supportive Care Drugs Market Overview
1.1.1 Cancer Therapeutics and Supportive Care Drugs Product Scope
1.1.2 Cancer Therapeutics and Supportive Care Drugs Market Status and Outlook
1.2 Global Cancer Therapeutics and Supportive Care Drugs Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Cancer Therapeutics and Supportive Care Drugs Market Size by Region (2018-2029)
1.4 Global Cancer Therapeutics and Supportive Care Drugs Historic Market Size by Region (2018-2023)
1.5 Global Cancer Therapeutics and Supportive Care Drugs Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Cancer Therapeutics and Supportive Care Drugs Market Size (2018-2029)
1.6.1 North America Cancer Therapeutics and Supportive Care Drugs Market Size (2018-2029)
1.6.2 Europe Cancer Therapeutics and Supportive Care Drugs Market Size (2018-2029)
1.6.3 Asia-Pacific Cancer Therapeutics and Supportive Care Drugs Market Size (2018-2029)
1.6.4 Latin America Cancer Therapeutics and Supportive Care Drugs Market Size (2018-2029)
1.6.5 Middle East & Africa Cancer Therapeutics and Supportive Care Drugs Market Size (2018-2029)
2 Cancer Therapeutics and Supportive Care Drugs Market by Type
2.1 Introduction
2.1.1 Cancer Therapeutics
2.1.2 Supportive Care Drugs
2.2 Global Cancer Therapeutics and Supportive Care Drugs Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Cancer Therapeutics and Supportive Care Drugs Historic Market Size by Type (2018-2023)
2.2.2 Global Cancer Therapeutics and Supportive Care Drugs Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Cancer Therapeutics and Supportive Care Drugs Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Cancer Therapeutics and Supportive Care Drugs Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Cancer Therapeutics and Supportive Care Drugs Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Cancer Therapeutics and Supportive Care Drugs Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Cancer Therapeutics and Supportive Care Drugs Revenue Breakdown by Type (2018-2029)
3 Cancer Therapeutics and Supportive Care Drugs Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Retail Pharmacies
3.2 Global Cancer Therapeutics and Supportive Care Drugs Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Cancer Therapeutics and Supportive Care Drugs Historic Market Size by Application (2018-2023)
3.2.2 Global Cancer Therapeutics and Supportive Care Drugs Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Cancer Therapeutics and Supportive Care Drugs Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Cancer Therapeutics and Supportive Care Drugs Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Cancer Therapeutics and Supportive Care Drugs Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Cancer Therapeutics and Supportive Care Drugs Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Cancer Therapeutics and Supportive Care Drugs Revenue Breakdown by Application (2018-2029)
4 Cancer Therapeutics and Supportive Care Drugs Competition Analysis by Players
4.1 Global Cancer Therapeutics and Supportive Care Drugs Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cancer Therapeutics and Supportive Care Drugs as of 2022)
4.3 Date of Key Players Enter into Cancer Therapeutics and Supportive Care Drugs Market
4.4 Global Top Players Cancer Therapeutics and Supportive Care Drugs Headquarters and Area Served
4.5 Key Players Cancer Therapeutics and Supportive Care Drugs Product Solution and Service
4.6 Competitive Status
4.6.1 Cancer Therapeutics and Supportive Care Drugs Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Cancer Therapeutics and Supportive Care Drugs Products, Services and Solutions
5.1.4 Abbott Laboratories Cancer Therapeutics and Supportive Care Drugs Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Laboratories Recent Developments
5.2 AstraZeneca plc
5.2.1 AstraZeneca plc Profile
5.2.2 AstraZeneca plc Main Business
5.2.3 AstraZeneca plc Cancer Therapeutics and Supportive Care Drugs Products, Services and Solutions
5.2.4 AstraZeneca plc Cancer Therapeutics and Supportive Care Drugs Revenue (US$ Million) & (2018-2023)
5.2.5 AstraZeneca plc Recent Developments
5.3 Astellas Pharma
5.3.1 Astellas Pharma Profile
5.3.2 Astellas Pharma Main Business
5.3.3 Astellas Pharma Cancer Therapeutics and Supportive Care Drugs Products, Services and Solutions
5.3.4 Astellas Pharma Cancer Therapeutics and Supportive Care Drugs Revenue (US$ Million) & (2018-2023)
5.3.5 Bristol-Myers Squibb Recent Developments
5.4 Bristol-Myers Squibb
5.4.1 Bristol-Myers Squibb Profile
5.4.2 Bristol-Myers Squibb Main Business
5.4.3 Bristol-Myers Squibb Cancer Therapeutics and Supportive Care Drugs Products, Services and Solutions
5.4.4 Bristol-Myers Squibb Cancer Therapeutics and Supportive Care Drugs Revenue (US$ Million) & (2018-2023)
5.4.5 Bristol-Myers Squibb Recent Developments
5.5 Johnson & Johnson
5.5.1 Johnson & Johnson Profile
5.5.2 Johnson & Johnson Main Business
5.5.3 Johnson & Johnson Cancer Therapeutics and Supportive Care Drugs Products, Services and Solutions
5.5.4 Johnson & Johnson Cancer Therapeutics and Supportive Care Drugs Revenue (US$ Million) & (2018-2023)
5.5.5 Johnson & Johnson Recent Developments
5.6 Eli Lilly
5.6.1 Eli Lilly Profile
5.6.2 Eli Lilly Main Business
5.6.3 Eli Lilly Cancer Therapeutics and Supportive Care Drugs Products, Services and Solutions
5.6.4 Eli Lilly Cancer Therapeutics and Supportive Care Drugs Revenue (US$ Million) & (2018-2023)
5.6.5 Eli Lilly Recent Developments
5.7 Novartis
5.7.1 Novartis Profile
5.7.2 Novartis Main Business
5.7.3 Novartis Cancer Therapeutics and Supportive Care Drugs Products, Services and Solutions
5.7.4 Novartis Cancer Therapeutics and Supportive Care Drugs Revenue (US$ Million) & (2018-2023)
5.7.5 Novartis Recent Developments
5.8 Pfizer
5.8.1 Pfizer Profile
5.8.2 Pfizer Main Business
5.8.3 Pfizer Cancer Therapeutics and Supportive Care Drugs Products, Services and Solutions
5.8.4 Pfizer Cancer Therapeutics and Supportive Care Drugs Revenue (US$ Million) & (2018-2023)
5.8.5 Pfizer Recent Developments
5.9 Sanofi
5.9.1 Sanofi Profile
5.9.2 Sanofi Main Business
5.9.3 Sanofi Cancer Therapeutics and Supportive Care Drugs Products, Services and Solutions
5.9.4 Sanofi Cancer Therapeutics and Supportive Care Drugs Revenue (US$ Million) & (2018-2023)
5.9.5 Sanofi Recent Developments
5.10 Teva Pharmaceuticals
5.10.1 Teva Pharmaceuticals Profile
5.10.2 Teva Pharmaceuticals Main Business
5.10.3 Teva Pharmaceuticals Cancer Therapeutics and Supportive Care Drugs Products, Services and Solutions
5.10.4 Teva Pharmaceuticals Cancer Therapeutics and Supportive Care Drugs Revenue (US$ Million) & (2018-2023)
5.10.5 Teva Pharmaceuticals Recent Developments
5.11 Takeda Pharmaceuticals
5.11.1 Takeda Pharmaceuticals Profile
5.11.2 Takeda Pharmaceuticals Main Business
5.11.3 Takeda Pharmaceuticals Cancer Therapeutics and Supportive Care Drugs Products, Services and Solutions
5.11.4 Takeda Pharmaceuticals Cancer Therapeutics and Supportive Care Drugs Revenue (US$ Million) & (2018-2023)
5.11.5 Takeda Pharmaceuticals Recent Developments
5.12 AbbVie
5.12.1 AbbVie Profile
5.12.2 AbbVie Main Business
5.12.3 AbbVie Cancer Therapeutics and Supportive Care Drugs Products, Services and Solutions
5.12.4 AbbVie Cancer Therapeutics and Supportive Care Drugs Revenue (US$ Million) & (2018-2023)
5.12.5 AbbVie Recent Developments
6 North America
6.1 North America Cancer Therapeutics and Supportive Care Drugs Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Cancer Therapeutics and Supportive Care Drugs Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Cancer Therapeutics and Supportive Care Drugs Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Cancer Therapeutics and Supportive Care Drugs Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Cancer Therapeutics and Supportive Care Drugs Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Cancer Therapeutics and Supportive Care Drugs Market Dynamics
11.1 Cancer Therapeutics and Supportive Care Drugs Industry Trends
11.2 Cancer Therapeutics and Supportive Care Drugs Market Drivers
11.3 Cancer Therapeutics and Supportive Care Drugs Market Challenges
11.4 Cancer Therapeutics and Supportive Care Drugs Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
